Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids

D. Johnson, J. Gottanka, C. Flugel, F. Hoffmann, R. Futa and E. Lutjen-Drecoll
Department of Ophthalmology, Mayo Clinic, Rochester, Minn, USA.

OBJECTIVES: To study the ultrastructure of the trabecular meshwork in human eyes with corticosteroid-induced glaucoma and to determine whether the changes noted also occur in the eyes of patients with primary open-angle glaucoma (POAG) who have been treated with corticosteroids. METHODS: The trabecular meshwork from 5 patients in whom corticosteroid-induced glaucoma was diagnosed and from 6 patients with POAG who had been treated with systemic or topical corticosteroids for months to years was investigated with light and electron microscopy. None of the eyes with POAG were considered to have corticosteroid-induced elevation of the intraocular pressure. RESULTS: Eyes with corticosteroid-induced glaucoma had the accumulation of extracellular material distinct from the sheath-derived plaques typical of POAG. A finger-printlike arranged material resembling basement membranes (FBM material), considered characteristic of corticosteroid-induced glaucoma, was found in all eyes with corticosteroid-induced glaucoma. In addition, an abnormal accumulation of densely packed, fine fibrils immediately beneath the inner wall endothelium of Schlemm's canal was present. The findings were similar among patients receiving topical or systemic treatment and among patients of different ages. In the eyes from donors with POAG who had been treated with corticosteroids, the fine fibrillar material and FBM material were present in small amounts in 3 of 6 donors and were not found in the other 3 donors. CONCLUSIONS: The extracellular material that accumulates in eyes with corticosteroid-induced glaucoma differs from that seen in eyes with POAG. Eyes with POAG exposed to long-term corticosteroid treatment did not all respond with the formation of the abnormal extracellular materials characteristic of those found in eyes with corticosteroid-induced glaucoma.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Determining the Pharmacological Activity of Physalis peruviana Fruit Juice on Rabbit Eyes and Fibroblast Primary Cultures
Pardo et al.
IOVS 2008;49:3074-3079.
ABSTRACT | FULL TEXT  

Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma
Gould et al.
Mol. Cell. Biol. 2006;26:8427-8436.
ABSTRACT | FULL TEXT  

Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma
Gould et al.
Mol. Cell. Biol. 2004;24:9019-9025.
ABSTRACT | FULL TEXT  

Altered Peripheral Sensitivity to Glucocorticoids in Primary Open-Angle Glaucoma
Stokes et al.
IOVS 2003;44:5163-5167.
ABSTRACT | FULL TEXT  

Distribution of Myocilin and Extracellular Matrix Components in the Corneoscleral Meshwork of Human Eyes
Ueda and Yue
IOVS 2003;44:4772-4779.
ABSTRACT | FULL TEXT  

Tissue Differential Microarray Analysis of Dexamethasone Induction Reveals Potential Mechanisms of Steroid Glaucoma
Lo et al.
IOVS 2003;44:473-485.
ABSTRACT | FULL TEXT  

Effects of Elevated Intraocular Pressure on Outflow Facility and TIGR/MYOC Expression in Perfused Human Anterior Segments
Borras et al.
IOVS 2002;43:33-40.
ABSTRACT | FULL TEXT  

Glucocorticoid Induction of the Glaucoma Gene MYOC in Human and Monkey Trabecular Meshwork Cells and Tissues
Clark et al.
IOVS 2001;42:1769-1780.
ABSTRACT | FULL TEXT  

Induction of Tissue Transglutaminase in the Trabecular Meshwork by TGF-{beta}1 and TGF-{beta}2
Welge-Lüßen et al.
IOVS 2000;41:2229-2238.
ABSTRACT | FULL TEXT  

Myocilin and Glaucoma: A TIGR by the Tail?
Johnson
Arch Ophthalmol 2000;118:974-978.
ABSTRACT | FULL TEXT  

Distribution of Glucocorticoid and Mineralocorticoid Receptors and 11{beta}-Hydroxysteroid Dehydrogenases in Human and Rat Ocular Tissues
Stokes et al.
IOVS 2000;41:1629-1638.
ABSTRACT | FULL TEXT